News

Filter

Current filters:

None

7901 to 7910 of 98149 results

Pharma R&D internal rate of return falls for a second year but shows signs of stabilizing

04-12-2012

The R&D internal rate of return (IRR) of leading pharmaceutical companies has fallen for a second successive…

BiotechnologyFinancialPharmaceuticalResearch

AstraZeneca inks deal for Optimer's fidaxomicin in Latin America

04-12-2012

USA-based Optimer Pharmaceuticals (Nasdaq: OPTR) says it has executed an exclusive agreement with Anglo-Swedish…

Antibiotics and Infectious diseasesAstraZenecafidaxomicinLicensingOptimer PharmaceuticalsPharmaceuticalSouth America

US Congressman Cassidy, et al, propose drug shortage solutions

03-12-2012

US Congressman Bill Cassidy, a medical physician (Republican, Louisiana) and four colleagues, last week…

GenericsHealthcareLegalNorth AmericaPharmaceutical

Merck & Co moves Alzheimer's candidate MK-8931 into Ph II/III

03-12-2012

US drug giant Merck & Co (NYSE: MRK) says it has started a Phase II/III clinical trial designed to evaluate…

Merck & CoMK-8931NeurologicalPharmaceuticalResearch

PharmaEssentia gets certain Asian rights to Kinex' dermatology candidate KX01

03-12-2012

USA-based privately-held Kinex Pharmaceuticals has entered a licensing agreement granting Taiwan's PharmaEssentia…

Asia-PacificBiotechnologyDermatologicalsKinex PharmaceuticalsKX01LicensingPharmaEssentia

Time for government action on investing in neglected diseases R&D

03-12-2012

A five-year review of global neglected disease R&D funding shows that, despite increased investment of…

FinancialPharmaceuticalRare diseasesResearchTropical diseases

7901 to 7910 of 98149 results

Back to top